Find the investors funding Health Series B rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Japanese startup Celaid Therapeutics completes second close of Series B financing round with $2.6 M - BioSpectrum Asia
Celaid Therapeutics, a Japanese startup, has completed the second close of its Series B financing round, raising $2.6 million. The company operates in the health sector. Further details about the company's specific focus or the use of funds were not provided in the article.
Japanese startup Celaid Therapeutics completes second close of Series B financing round with $2.6 M BioSpectrum Asia
| Sep 25, 2026 | O-ID | $1.2M | Pre-seed | Japan |
| Sep 21, 2026 | ARK | $8.5M | Series A | Japan |
| Sep 17, 2026 | CADDi | $128.0M | — | Japan |
| Sep 15, 2026 | A Vinyl Bar | $5.5M | Pre-seed | Japan |
You just read who funded Celaid Therapeutics. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.